Follow
Janaki Amin
Janaki Amin
Professor of Public Health, Macqurie Univeristy
Verified email at mq.edu.au - Homepage
Title
Cited by
Cited by
Year
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, and meta-regression
R Waziry, B Hajarizadeh, J Grebely, J Amin, M Law, M Danta, J George, ...
Journal of hepatology 67 (6), 1204-1212, 2017
5232017
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection
J Grebely, K Page, R Sacks‐Davis, MS van der Loeff, TM Rice, J Bruneau, ...
Hepatology 59 (1), 109-120, 2014
5042014
Life expectancy of HIV‐positive people after starting combination antiretroviral therapy: a meta‐analysis
S Teeraananchai, SJ Kerr, J Amin, K Ruxrungtham, MG Law
HIV medicine 18 (4), 256-266, 2017
4912017
Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population
AJ Rodger, R Lodwick, M Schechter, S Deeks, J Amin, R Gilson, ...
Aids 27 (6), 973-979, 2013
4262013
Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial
A Carr, C Workman, DE Smith, J Hoy, J Hudson, N Doong, A Martin, ...
Jama 288 (2), 207-215, 2002
3952002
Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study
A Martin, DE Smith, A Carr, C Ringland, J Amin, S Emery, J Hoy, ...
Aids 18 (7), 1029-1036, 2004
3772004
Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study
J Amin, MG Law, M Bartlett, JM Kaldor, GJ Dore
The Lancet 368 (9539), 938-945, 2006
3432006
Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study
AE Grulich, R Guy, J Amin, F Jin, C Selvey, J Holden, HMA Schmidt, ...
The lancet HIV 5 (11), e629-e637, 2018
3362018
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial
J Grebely, O Dalgard, B Conway, EB Cunningham, P Bruggmann, ...
The lancet Gastroenterology & hepatology 3 (3), 153-161, 2018
3072018
Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial
A Martin, M Bloch, J Amin, D Baker, DA Cooper, S Emery, A Carr, ...
Clinical Infectious Diseases 49 (10), 1591-1601, 2009
3022009
The pattern of excess cancer in dialysis and transplantation
JH Stewart, CM Vajdic, MT Van Leeuwen, J Amin, AC Webster, ...
Nephrology Dialysis Transplantation 24 (10), 3225-3231, 2009
2422009
Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study
MT Van Leeuwen, AC Webster, MRE McCredie, JH Stewart, ...
Bmj 340, 2010
1962010
Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study
J Amin, GJ Dore, DL O’Connell, M Bartlett, E Tracey, JM Kaldor, MG Law
Journal of hepatology 45 (2), 197-203, 2006
1872006
HIV and hepatitis C coinfection within the CAESAR study
J Amin, M Kaye, S Skidmore, D Pillay, DA Cooper, GJ Dore
HIV medicine 5 (3), 174-179, 2004
1862004
Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority …
ENCORE1 Study Group
The Lancet 383 (9927), 1474-1482, 2014
1832014
Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study
J Grebely, FMJ Lamoury, B Hajarizadeh, Y Mowat, AD Marshall, S Bajis, ...
The lancet Gastroenterology & hepatology 2 (7), 514-520, 2017
1752017
Quantifying the dose-response of walking in reducing coronary heart disease risk: meta-analysis
H Zheng, N Orsini, J Amin, A Wolk, VTT Nguyen, F Ehrlich
European journal of epidemiology 24, 181-192, 2009
1702009
Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation
MT Van Leeuwen, AE Grulich, AC Webster, MRE McCredie, JH Stewart, ...
Blood, The Journal of the American Society of Hematology 114 (3), 630-637, 2009
1652009
A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naive individuals in Thailand
GV Matthews, A Avihingsanon, SR Lewin, J Amin, R Rerknimitr, ...
Hepatology 48 (4), 1062-1069, 2008
1652008
Specific antibody‐dependent cellular cytotoxicity responses associated with slow progression of HIV infection
LH Wren, AW Chung, G Isitman, AD Kelleher, MS Parsons, J Amin, ...
Immunology 138 (2), 116-123, 2013
1602013
The system can't perform the operation now. Try again later.
Articles 1–20